openPR Logo
Press release

Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside!

05-16-2024 12:12 AM CET | Energy & Environment

Press release from: ABNewswire

Recently, several companies have disclosed their financial results, attracting investor attention. According to "The Street Experts", investors should consider monitoring the following three stocks: Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE), originally reported on May 9, 2024 , when the stock price was below $0.10. (See link: https://thestreetreports.com/stocks-on-the-street-under-10%c2%a2-in-focus-ffie-spzi-hnrc-pegy-halb/), Plug Power Inc. (NASDAQ: PLUG), and SunPower Corporation (NASDAQ: SPWR) and four additional stocks are discussed in this news article.

Catheter Precision Inc. (NYSE American: VTAK): Known for its expertise in cardiac electrophysiology, the company disclosed its Q1 2024 financial results on May 6. Earnings reflected a narrower-than-anticipated loss at 36 cents per share, surpassing the forecasted 42 cents. During this quarter, Catheter Precision reported revenue of $820,000, with total assets valued at $28 million. At the close of the quarter, shareholder equity was reported at $18.5 million. Additionally, Catheter Precision recently secured new purchase orders from Ronald Reagan UCLA Medical Center Rady Children's Hospital (UCLA), University of California San Diego Health System (UCSD) and HCA Healthcare Inc. (NYSE: HCA).

Intelligent Bio Solutions (NASDAQ: INBS) On May 9, disclosed its financial performance for Q3 of fiscal year 2024. The company reported a loss of $1.43 per share, which was notably better than analysts' expectations of a $2.52 loss per share. However, the reported revenue of $823,800 for the quarter fell short of the projected $1.08 million. The company highlighted its revenue growth during the quarter, attributing it to the acquisition of 26 new accounts and a consistent expansion in its installed base.

Peraso Inc. (NASDAQ: PRSO), recognized as a leading authority in mmWave technology for 60 GHz 5G networks, both unlicensed and licensed, which are integrated into Panasonic Corporation's (Tokyo: 6752.T) (OTC: PCRFF) systems across Japan, announced its fiscal Q1 2024 financial outcomes on May 13. The company reported a net revenue of $2.8 million for the quarter, marking a significant increase from the $1.8 million recorded in the previous quarter and surpassing Wall Street expectations.

Dyadic International Inc. (NASDAQ: DYAI), a biotechnology firm engaged in large-scale protein production for use in human and animal vaccines and therapeutics, disclosed its financial outcomes for Q1 2024 on May 14. At the quarter's conclusion, Dyadic International reported having $12.1 million in cash, cash equivalents, and securities, an increase from $7.3 million as of December 31, 2023. The company recorded revenues of $335,000 for the quarter, a decrease from the $934,000 reported in the same period the previous year. The company emphasized its ongoing efforts to implement its business strategy during the quarter. 2024 Strategy to enter the food and beverage industry, aiming to effectively cater to the growing demand for "Future of Foods."

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=top-stocks-to-watch-ffie-plug-spwr-more-inside]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside! here

News-ID: 3498259 • Views:

More Releases from ABNewswire

Chronic Wounds Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE
Chronic Wounds Market Dynamics Indicate Upward Trajectory Through 2034, Reports …
The Key Chronic Wounds Companies in the market include - Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE, and others. The Chronic Wounds market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Wounds pipeline products will significantly revolutionize the Chronic Wounds market dynamics. DelveInsight's "Chronic Wounds Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Chronic Wounds,
High-grade Glioma Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Rigel Pharmac, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma
High-grade Glioma Market to Experience Notable Growth in Forecast Span by 2034, …
The Key High-grade Glioma Companies in the market include - Everfront Biotech Co., Ltd., BioMimetix JV, LLC, Chimerix, Laminar Pharmaceuticals, Nationwide Children's Hospital, Rigel Pharmaceuticals, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharmaceuticals, VBI Vaccines, Kazia Therapeutics, Aivita Biomedical, Medicenna Therapeutics, DelMar Pharmaceuticals, Bristol-Myers Squibb, Laminar Pharmaceuticals, Immunomic Therapeutics, Inovio Pharmaceuticals, and others. DelveInsight's "High-grade Glioma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the High-grade
Cutaneous Lupus Erythematosus Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Biogen, Horizon Therapeutics, Bristol-Myers Squibb, AstraZeneca, Sanofi, Amgen, Gilead
Cutaneous Lupus Erythematosus Market Insights Highlight Expanding Outlook Till 2 …
The Key Cutaneous Lupus Erythematosus Companies in the market include - Biogen, Horizon Therapeutics, Bristol-Myers Squibb, AstraZeneca, Sanofi, Amgen, Biogen, Gilead Sciences, Pfizer, Bristol-Myers Squibb, Novartis, Rigel Pharmaceuticals, Merck, and others. DelveInsight's "Cutaneous Lupus Erythematosus Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cutaneous Lupus Erythematosus, historical and forecasted epidemiology as well as the Cutaneous Lupus Erythematosus market trends in the United States, EU4 (Germany, Spain,
Starry Venus Submits Album SOUL for Grammy Registered Consideration, Marking a Defining Moment in Her Artistic Journey
Starry Venus Submits Album SOUL for Grammy Registered Consideration, Marking a D …
Sedona, AZ - Visionary artist Starry Venus has officially submitted her album SOUL for Grammy Registered consideration, a milestone that underscores her growing influence as a boundary-pushing voice in today's music scene. Known for her ethereal soundscapes and empowering lyrical narratives, Starry Venus captivates audiences with music that blends artistry, spirituality, and authenticity. The submitted album, SOUL, showcases Starry Venus's ability to fuse raw emotion with expansive sound design across multiple

All 5 Releases


More Releases for NASDAQ:

Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release. Financials Mischaracterized, Says Peraso Peraso rebuffed Mobix's
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders
Investigation announced for Investors in NASDAQ: MTTR over possible Wrongdoing a …
An investigation was announced for investors in shares of Matterport, Inc. (NASDAQ: MTTR) was announced over potential breaches of fiduciary duties by certain officers and directors at Matterport, Inc. Investors who purchased shares of Matterport, Inc. (NASDAQ: MTTR) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Matterport, Inc. directors breached their fiduciary duties and